NCT06879288View on ClinicalTrials.gov

Dexmedetomidine Versus Magnesium Sulfate as Adjuvants to Intraperitoneal Bupivacaine for Postoperative Analgesia After Elective Laparoscopic Cholecystectomy

NACompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

July 1, 2023

Primary Completion Date

February 1, 2025

Study Completion Date

February 1, 2025

Conditions
DexmedetomidineMagnesium SulfateAdjuvantsIntraperitoneal BupivacainePostoperative AnalgesiaElective Laparoscopic Cholecystectomy
Interventions
DRUG

Bupivacaine

Patients received intraperitoneal bupivacaine only at the end of the operations.

DRUG

Dexmedetomidine

Patients received intraperitoneal bupivacaine plus dexmedetomidine at the end of the operations.

DRUG

Magnesium sulfate

Patients received intraperitoneal bupivacaine plus magnesium sulfate at the end of the operations.

Trial Locations (1)

31527

Tanta University, Tanta

All Listed Sponsors
lead

Tanta University

OTHER